Many of you are aware that Basel’s annual MipTec conference on drug discovery draws 3000 participants from over 50 countries.  And year after year, we host over 100 scientific talks, 150 poster presentations, 10 industry symposia, and more than 100 exhibitors, covering a wide array of topics touching every facet of basic and applied research activities.  A true reflection of the breadth of these activities compelled us to title the 2015 science conference as “Basel Life Science Week” and the MipTec Exhibition.

Thus, it is with heartfelt gratitude that we extend this warm welcome to Basel Life Science Week (BLSW) and the MipTec exhibition.  It is an exciting time for life science research, as many fundamental discoveries in laboratories around the world have transitioned into break through applications for human health.

CRISPR mediated gene editing is enabling faster developments in gene therapy, Chimeric Antigen Receptor T-cells (CARTs) are making possible complete remission from leukemia, and breakthroughs in technologies, for example in NGS and Mass cytometry, are allowing sensitive analysis of cells to usher in the era of precision medicine.

At the Basel Life Science Week and the MipTec exhibition, we continue to bring inspired people together in cross disciplinary forums to ensure research applied to human health remains at the cutting edge.

We are proud to announce that the Keynote Lecture series will feature Dr. Jean-Paul Clozel, CEO of Actelion, Dr. Kushru Asadullah, Professor at Charite and former VP Biomarkers at Bayer, and Dr. John Reed, Head of Pharma Research & Early Development (pRED), Roche.

The 2015 science programmeme will have multiple streams with leading science experts covering advances in Aging, Cell signaling, Medicinal chemistry, Synergy of combination drug therapies, Next Generation Sequencing applications, Information management, Stem cells, Peptide therapies, GPCRs and Translational Medicine. In addition, the annual MipTec Industry Exhibition, networking socials, lunch hour symposia, poster presentations, and pre-conference workshops will allow for enhanced learning.

We want to thank each of you for attending the conference and bringing your energy and expertise to the gathering. You have the vision, the knowledge, the ability and the experience to help us pave our way into the future and we could not accomplish what we do without your support. Throughout this conference, we ask you to stay engaged, keep us proactive and help us shape the future of life science research and health care.

Our personal respect and thanks goes out to all of you and we look forward to seeing you at the conference,

BLSW Steering Committee

Bhupinder Bhullar Novartis Pharma AG (Basel, CH) – Chair of Steering Committee
Gregor Dernick F. Hoffman-La Roche (Basel, CH)    – Scientific Program Chair
Martin Fussenegger ETH (Basel & Zurich, CH)         – Strategic Advisory Chair
Roland Bucher Bucher Biotec AG (Basel,CH)           – Exhibitor Representative
Sabine Adam  Congrex Switzerland (Basel, CH)      – Account Director

Keynote Speakers

Dr. John Reed – Head of Pharma Research & Early Development (pRED) , Roche
Date: Tuesday, September 22, 2015
Time: 13.35 – 14.20

Lecture title: tbd

Dr. Jean-Paul Clozel – CEO and Co-Founder, Actelion
Date: Wednesday, September 23, 2015
Time: 13.30 – 14.15

Lecture title: tbd

Prof. Dr. med. Kushru Asadullah – Professor, Charité Medical Center, and former Bayer Healthcare Vice-President & Global head of Biomarkers
Date: Thursday, September 24, 2015
Time: 13.30 – 14.15

Lecture title: tbd